CompaniesByCap
TVTX
Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare

Travere Therapeutics Inc. Income Statement 2011–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Feb 2012Feb 2011
Revenues
Revenue490.7M233.2M145.2M109.5M131.8M198.3M175.3M164.2M154.9M133.6M00
Gross Profit
Profitability
Operating Income-62.8M-323.8M-388.1M-319.8M-199.4M-176.2M-137.4M-80.0M-53.8M-58.2M
EBITDA
Net Income-25.5M-321.5M-111.4M-278.5M-180.1M-169.4M-146.4M-102.7M-59.7M-47.9M-14,825-23,022
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)89M79M74M64M60M48M42M40M39M38M0M

Travere Therapeutics Inc. Income Statement — FAQ

Travere Therapeutics Inc. (TVTX) income statement over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TVTX's income statement history?

The chart and table above show Travere Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.